COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
07/05/2026
Company announcement No. 13 / 2026 Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program Robust cash position of USD 2.3 billion (DKK 14.5 billion) as of March 31, 2026 Financial strength to [...]
Zelluna ASA: First Quarter 2026 results
07/05/2026
Oslo, 7 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today presents its results for the [...]
Zealand Pharma Announces Financial Results for the First Three Months of 2026
07/05/2026
Company announcement – No. 14 / 2026 Zealand Pharma Announces Financial Results for the First Three Months of 2026 A defining start to 2026, marked by pivotal progress for leading obesity assets, petrelintide and [...]
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
07/05/2026
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4. [...]
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
07/05/2026
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to [...]
Zealand Pharma - Execution framework for share buy-back program
07/05/2026
Company announcement No. 15 / 2026 Zealand Pharma - Execution framework for share buy-back program Copenhagen, Denmark, May 7, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. [...]
Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
07/05/2026
Leiden, the Netherlands, May 7, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced presentations at the 2026 Annual Meeting of the Clinical Immunology [...]
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
07/05/2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth Schlieren (Zurich), Switzerland, May 7, 2026 – Kuros Biosciences (“ [...]
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
07/05/2026
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche's digital pathology portfolio to drive laboratory efficiency Combining Roche’s strong [...]
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
07/05/2026
As Part of the Settlement, Hetero Labs Ltd. Receives a License to Market Generic FIRDAPSE Beginning in January 2035 Catalyst has No Other FIRDAPSE Patent Litigation Pending CORAL GABLES, Fla., May 07, 2026 (GLOBE [...]
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
07/05/2026
$1.3 billion in first quarter global product net sales, representing 63% year-over-year growth Anti - AChR antibody negative (“seronegative”) gMG PDUFA is May 10, 2026 Management to host conference call today at 2:30 PM [...]
Suja Life Announces Pricing of Initial Public Offering
07/05/2026
OCEANSIDE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced the pricing of its initial public offering of 8,888,889 shares of its Class A common stock (“Class A Common Stock”) which are being [...]
SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support
07/05/2026
SteelPower Male Enhancement Scam Searches, Complaints, Ingredients, Refund Policy, and Pricing Explained for 2026 Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and [...]
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
07/05/2026
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritten public offering of 9,859,155 shares of its common stock at a price [...]
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
JERSEY CITY, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) (“SCYNEXIS” or the “Company”), a biotechnology company focused on developing innovative new therapies to address severe rare diseases [...]
InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China
07/05/2026
BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
07/05/2026
Data contributed to the scientific and clinical rationale for RASolute 302, a pivotal Phase 3 trial in second line treatment of patients with metastatic pancreatic cancer REDWOOD CITY, Calif., May 06, 2026 (GLOBE [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2026 Financial Results on May 8, 2026
07/05/2026
FREDERICK, Md., May 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
InsuLeaf Claims Evaluated: The Safer & More Effective than GLP-1 Drugs, Natural Leak Peak Formula
07/05/2026
How InsuLeaf's Chromium, Alpha Lipoic Acid, Cinnamon, Gymnema sylvestre, and Bitter Melon Blood Sugar Support Formula Compares to GLP-1 Drug Searches in 2026 Largo, FL, May 06, 2026 (GLOBE NEWSWIRE) -- The phrase "safer [...]

Pages